Andrew Singleton and Ellen Sidransky Lauded for Genetics Research
Throughout history, some of the most important insights about devastating illnesses have come from identifying genes that contribute to them. Parkinson’s disease, a neurological condition that robs patients of the ability to move, is just one example of this pattern — and one that IRP researchers have made critical advances on in recent years.
Reflecting the IRP’s groundbreaking research on Parkinson’s disease, in September, IRP senior investigators Ellen Sidransky, M.D., and Andrew Singleton, Ph.D., were awarded the prestigious Breakthrough Prize for their research on the genetic causes of the illness. The world’s largest scientific award, the Breakthrough Prize honors “transformative advances toward understanding living systems and extending human life.” Each year, one award in the Life Sciences category is reserved for research on Parkinson’s and other neurodegenerative disorders. Dr. Sidransky and Dr. Singleton, along with a third Parkinson’s researcher, Thomas Gasser, M.D., Ph.D., at the University of Tübingen in Germany, will share the $3 million prize.
Less Powerful Magnetic Fields Improve Heart and Lung Imagery
On November 8, 1895, a physics professor in Bavaria was working in his darkened laboratory when he noticed glimmers of light breaking through a piece of heavy black paper and lighting up a screen behind it. As he placed thicker and heavier items between the source of light and the screen, the light remained. That was the day Wilhelm Röntgen accidentally discovered x-rays and changed medicine forever.
As we celebrate World Radiology Day on the 128th anniversary of that discovery, medical imaging now allows people to see inside the human body with a clarity Dr. Röntgen scarcely could have imagined. Magnetic resonance imaging (MRI), in particular, has seen huge advances due to the development of bigger and stronger magnets. In contrast to that trend, IRP Stadtman Investigator Adrienne Campbell-Washburn, Ph.D., has instead combined better software and hardware with a less powerful magnetic field to create a new type of ‘low-field’ MRI that is particularly useful for taking pictures of the heart and lungs and for guiding minimally invasive procedures.
The cumulative years of experience among the IRP’s large cadre of cancer researchers is truly astounding, with numerous scientists having spent half a century or more studying the disease at NIH. As incredibly valuable as their hard-earned wisdom is to finding new treatments for cancer, any scientific field also benefits tremendously from a constant influx of young talent. That’s where the IRP’s Lasker Clinical Research Scholars Program comes in.
The Lasker program identifies extremely promising early-career physician-scientists in a wide variety of fields and provides them with funding and resources to start their own independent labs at NIH. Over the past year, purely by coincidence, all of the Lasker Scholars selected happen to specialize in the study and treatment of cancer. Read on to learn more about the new ideas and bounding enthusiasm these fresh faces are bringing to NIH’s fight against the disease.
Insights From Mouse Study Could Aid Treatment for Opioid Use Disorder
A headache or stubbed toe is annoying enough as it is, but for people in recovery from opioid use disorder, everyday aches and pains — and even sensations that would ordinarily not be painful at all — can be amped up to the point that they become quite distressing. A new IRP mouse study has helped scientists home in on the specific brain cells that might cause this phenomenon, providing a first step towards an intervention that could make it easier for people to stop using addictive opioid medications or illegal drugs like heroin.
As legendary chef James Beard once said, “Food is our common ground, a universal experience.” Beyond a basic need to stay alive and obtain healthful nutrients, food is a source of pleasure, a reflection of culture, and a link to others. However, for many of us, food is also a challenge. There’s the food we love and the food that’s good for us, and the two aren’t always the same.
As we celebrate World Food Day on October 16, we spoke with IRP senior investigator Tonja Nansel, Ph.D., who is seeking explanations for the nutritional choices we make.
“The dietary quality of the U.S. population is well below recommended guidelines, and that’s the case regardless of income, education, and background,” Dr. Nansel says. “Simply put, we’re all eating badly.”
Traditional ways of assessing the effectiveness and safety of potential new drugs don’t exactly mimic the human body. After all, we are not jumbo-sized mice, nor are we flat swaths of a single type of cell spread across a petri dish. As a result, many drugs that initially show promising results when tested on cell or animal models turn out to be disappointing in clinical trials.
That’s why scientists like the IRP’s Marc Ferrer, Ph.D., are developing more realistic models of human tissues, which give a more accurate picture of how well a drug might work in people. As we observe Eczema Awareness Month in October, we spoke with Dr. Ferrer, Director of NIH’s 3D Tissue Bioprinting Laboratory, about the efforts of his group to create a better model of human skin for testing treatments for that condition, which causes dry, itchy skin for more than 30 million Americans.
As hard as IRP scientists work in the lab, they work equally hard to make sure their findings have a real-world impact on patients’ lives. The pathway from the lab to the clinic, though, is rarely straightforward — something IRP senior investigator Carlos Zarate Jr, M.D., knows first-hand from his game-changing innovations in treating depression.
Dr. Zarate closed this year’s NIH Research Festival on September 22 by describing that odyssey in the 16th annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. Named in honor of the former IRP investigator who established NIH’s Office of Technology Transfer in 1986, the annual event celebrates important IRP innovations that have moved beyond the boundaries of NIH.
Existing Medications Could Extend Procedure’s Protective Effects
While modern surgery is undoubtedly a life-saving modern marvel, mucking around inside the human body rarely comes without consequences. Certain life-extending procedures meant to combat heart disease, for instance, commonly cause cardiovascular complications of their own. Fortunately, a team led by IRP researchers has identified a promising approach for staving off those surgical side effects to keep patients’ hearts robust for longer.
Overactive Immune Response Sets Stage for Infection
Fungal infections are a serious medical threat to many people, especially those who are critically ill or have weakened immune systems. What’s more, outbreaks are on the rise, as studies show that rising global temperatures are causing fungi to evolve into new strains and grow in regions that were once too cold for comfort. Recent outbreaks include a tragic incident at a Michigan paper mill that sickened nearly 100 people and caused one death, as well as a cluster of fungal infections that have killed at least seven women who underwent cosmetic surgery at clinics in Mexico.
Commemorating Fungal Disease Awareness Week this week brings attention to the importance of combating fungal threats to our well-being. The theme this year is ‘Think Fungus,’ and that’s exactly what IRP senior investigator Michail Lionakis, M.D., Sc.D., has been doing for the last 20 years.
Mouse Study Could Lead to New Therapies for a Variety of Ailments
In most parts of your brain, the set of neurons you’re born with is what you’ve got for life — just like your fingers and toes, if you lose any, they’re not coming back. The body does have ways to encourage healing after a brain injury, but they are extremely constrained. However, by lending those natural systems a helping hand, IRP researchers have managed to dramatically boost regeneration and recovery of vision in mice with damage to the nerves that connect the eyes to the brain, an approach that could one day help people recover from other types of nervous system injuries as well.
This page was last updated on Friday, January 14, 2022